EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
Enteroviruses (EVs) are the most common viral agents in humans. Although most infections are mild or asymptomatic, there is a wide spectrum of clinical manifestations that may be caused by EV infections with varying degrees of severity. Among these viruses, EV-A71 and coxsackievirus (CV) CV-A16 from...
Main Authors: | Qunying Mao, Yiping Wang, Lianlian Bian, Miao Xu, Zhenglun Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1038/emi.2016.73 |
Similar Items
-
Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
by: Salima Lalani, et al.
Published: (2021-08-01) -
Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01) -
Valine/isoleucine variants drive selective pressure in the VP1 sequence of EV-A71 enteroviruses
by: Nghia Ngu Duy, et al.
Published: (2017-05-01) -
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Salima S. Lalani, et al.
Published: (2020-03-01) -
Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy
by: Pei Liu, et al.
Published: (2021-04-01)